Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review

As the use of immune checkpoint inhibitors (ICIs) in treating a variety of cancer types has increased in recent years, so too have the number of reports on patients acquiring resistance to these therapies. Overcoming acquired resistance to immunotherapy remains an important need in the field of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gim, Gahyun, Kim, Yeseul, Park, Yeonggyeong, Kim, Min Jeong, Nam, Myungwoo, Yang, Woojung, Duarte, Samantha E, Jung, Chan Mi, Vagia, Elena, Viveiros, Pedro, Chae, Young Kwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Medicine Clinic: Molecular Tumor Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256028/
https://www.ncbi.nlm.nih.gov/pubmed/35640145
http://dx.doi.org/10.1093/oncolo/oyac095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256028/
https://www.ncbi.nlm.nih.gov/pubmed/35640145
http://dx.doi.org/10.1093/oncolo/oyac095

Ejemplares similares